CGB 0.00% 2.1¢ cann global limited

Ann: WESTERN SYDNEY UNIVERSITY TO UNDERTAKE CLINICAL TRIALS, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,011 Posts.
    lightbulb Created with Sketch. 454
    100%

    I would like to see what was achieved for the $2 million we have already spent.

    No guidance of what they expect to further spend in Australia.

    If Australia was the right place to do the research, why did they not choose this from the beginning? They were located here. Many other companies already researching here. It seems to be an obvious choice?

    Also very interesting to have a look at the current NICM clinical trials.

    https://www.westernsydney.edu.au/nicm/research/clinical_trials
    https://hotcopper.com.au/data/attachments/3068/3068804-7eb3bbaacc24e9311900886bce3d96b6.jpg

 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.